IMR Press / FBL / Volume 22 / Issue 3 / DOI: 10.2741/4498

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Inflammatory biomarkers of coronary heart disease

Show Less
1 Department of Cardiology, Baotou Central Hospital, Baotou, China
2 Department of Radiology, Baotou Central Hospital, Baotou, China
3 Department of Surgery, Baotou Central Hospital, Baotou, China
Front. Biosci. (Landmark Ed) 2017, 22(3), 504–515;
Published: 1 January 2017
(This article belongs to the Special Issue Cellular immunology and stem cell biology)

Coronary heart disease (CHD), characterized by inflammation and accumulation of plaques mainly comprised of lipids, calcium and inflammatory cells in the walls of coronary arteries. CHD is exacerbated by specific cardiovascular risk factors, such as obesity, diabetes mellitus, and hypertension. The current review focuses on the critical role of traditional inflammatory biomarkers, including interleukin-6, C-reactive protein (CRP), complement, CD40 and myeloperoxidase (MPO), in the pathogenesis of CHD.

Coronary heart disease
C-reactive protein
Back to top